Neonatal-Onset Refractory Thrombocytopenia and Anemia Associated With a Homozygous In-Frame NFE2 Duplication

Objective:Rare disease Background:NFE2 encodes p45/NF-E2, a transcriptional regulator of megakaryocyte maturation and platelet production.However, germline NFE2-associated cytopenias are rare; consequently, the clinical spectrum is incompletely defined. Case Report:We report the case of a preterm neonate born to consanguineous parents who developed day-1-onset bicytopenia with transfusion-dependent thrombocytopenia and intermittent normocytic anemia.Initial evaluation did not support immune-mediated or consumptive causes; moreover, counts were refractory to intravenous immunoglobulin and romiplostim (a thrombopoietin-receptor agonist).Bone marrow examination showed dysmegakaryopoiesis with a paucity of late megakaryocyte forms, supporting defective terminal maturation.Trio sequencing with copy-number analysis identified a homozygous in-frame NFE2 duplication (c.889_900dup; p.Glu297_Arg300dup); both parents were heterozygous carriers, consistent with autosomal-recessive segregation.The duplication lies within the CNC region, adjacent to the basic leucine zipper module implicated in DNA binding and small Maf partner dimerization.Therefore, segregation, domain context, marrow morphology, and TPO-RA non-response implicate NFE2 as the leading etiologic signal, although the variant remains of uncertain significance. Conclusions:This case broadens the emerging NFE2 phenotype to neonatal-onset refractory bicytopenia with dysmegakaryopoiesis and, accordingly, supports a downstream p45/NF-E2 transcriptional maturation defect rather than impaired THPO-MPL signaling.Persistent neonatal cytopenias with dysmegakaryopoiesis and failure of immune-directed therapy and TPO-RA treatment should, therefore, prompt early germline evaluation, ideally trio sequencing with CNV analysis.Finally, targeted functional studies (transactivation, DNA binding, partner interaction) are needed to generate PS3-level evidence and enable definitive reclassification.

Authors

Institutions

Publication Details

Journal
American Journal of Case Reports
Published
2026-04-02
DOI
https://doi.org/10.12659/ajcr.952024
Primary Topic
Blood Coagulation and Thrombosis Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neonatal-Onset Refractory Thrombocytopenia and Anemia Associated With a Homozygous In-Frame NFE2 Duplication

Maan A Albehair, Mohammed Shahab Uddin, Fayez Nashi Motlaq Alshammari, Khaled Shafeen et al.
American Journal of Case Reports
Blood Coagulation and Thrombosis Mechanisms
article

Neonatal-Onset Refractory Thrombocytopenia and Anemia Associated With a Homozygous In-Frame NFE2 Duplication

Maan A Albehair, Mohammed Shahab Uddin, Fayez Nashi Motlaq Alshammari, Khaled Shafeen, Abdullah Bin Hassan, Amr Esmail, Hana Bawazier
article en

Abstract

Objective:Rare disease Background:NFE2 encodes p45/NF-E2, a transcriptional regulator of megakaryocyte maturation and platelet production.However, germline NFE2-associated cytopenias are rare; consequently, the clinical spectrum is incompletely defined. Case Report:We report the case of a preterm neonate born to consanguineous parents who developed day-1-onset bicytopenia with transfusion-dependent thrombocytopenia and intermittent normocytic anemia.Initial evaluation did not support immune-mediated or consumptive causes; moreover, counts were refractory to intravenous immunoglobulin and romiplostim (a thrombopoietin-receptor agonist).Bone marrow examination showed dysmegakaryopoiesis with a paucity of late megakaryocyte forms, supporting defective terminal maturation.Trio sequencing with copy-number analysis identified a homozygous in-frame NFE2 duplication (c.889_900dup; p.Glu297_Arg300dup); both parents were heterozygous carriers, consistent with autosomal-recessive segregation.The duplication lies within the CNC region, adjacent to the basic leucine zipper module implicated in DNA binding and small Maf partner dimerization.Therefore, segregation, domain context, marrow morphology, and TPO-RA non-response implicate NFE2 as the leading etiologic signal, although the variant remains of uncertain significance. Conclusions:This case broadens the emerging NFE2 phenotype to neonatal-onset refractory bicytopenia with dysmegakaryopoiesis and, accordingly, supports a downstream p45/NF-E2 transcriptional maturation defect rather than impaired THPO-MPL signaling.Persistent neonatal cytopenias with dysmegakaryopoiesis and failure of immune-directed therapy and TPO-RA treatment should, therefore, prompt early germline evaluation, ideally trio sequencing with CNV analysis.Finally, targeted functional studies (transactivation, DNA binding, partner interaction) are needed to generate PS3-level evidence and enable definitive reclassification.

American Journal of Case ReportsVol. 27
Semmelweis University (HU), National Guard Health Affairs (SA)
Good health and well-being
Openalex Percentile: Top 6%
Blood Coagulation and Thrombosis Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.